Business News

Solid debut! Molbio Diagnostics shares list at 21% premium over IPO price

FinSiddhi

The listing beat expectations as signalled by the grey market premium (GMP). Ahead of its debut today, Molbio Diagnostics IPO GMP was ₹120, suggesting 15 per cent listing pop.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

This sector is set to dominate Q1 earnings for all the wrong reasons

Oil marketing companies are set to dominate Q1 earnings but for the wrong reasons, with HPCL, BPCL and IOCL expected to post massive losses as elevated crude prices crushed fuel marketing margins. The sharp earnings hit is likely to overshadow profit growth in financials, telecom and metals, dragging overall India Inc. earnings.

‘Priyanka Chopra is best thing to come out of India after yoga’: Manager Anjula Acharia recalls seven years of struggle before ‘Quantico’ breakthrough

Priyanka Chopra Jonas’s manager detailed seven years of dedicated effort before her Hollywood breakthrough. Anjula Acharia emphasized Chopra’s lack of ego and willingness to start anew in America. Acharia believed Chopra possessed a unique quality that promised international success. Chopra’s initial music venture failed, leading to a pivot towards television roles. Quantico provided the first…